Position Summary:
Apellis is seeking a passionate and talented marketer for the role of Senior Product Manager, US Marketing - Nephrology. It is an outstanding opportunity to make a significant impact for patients, HCPs and the company, building and executing the US launch and marketing plan for the rare disease team at Apellis.
The US Senior Product Manager will be responsible for executing key marketing initiatives, and will work closely with the US Brand Lead to ensure initiatives are closely tied to the brand strategy. This role requires cross functional leadership across multiple internal functional areas to develop and execute the operational plan and tactics.
Key Responsibilities Include:
- Help to build and execute US launch plan for new nephrology indication
- Lead the development of personal and non-personal tactics, including but not limited to sales force resources, HCP congress activities, digital resources (e.g. websites, email campaigns), and media execution
- Play a key role in driving US Brand Planning – inclusive of defining stakeholder strategies - and budget development
- Help define and execute the vision and plan for US marketing. Manage agencies in the execution of that plan
- Develop field execution strategy for HCP-facing initiatives in partnership with training and sales leadership and patient services leadership
- Develop a multi-channel/digital strategy and measurement plan
- Develop the overall tactical measurement plan and develop courses of action based on these metrics
- Support NSM and POA strategy and execution
- Efficiently and thoughtfully administer the US marketing budget
- Work closely with regulatory, legal, and compliance to build policies and procedures related to HCP marketing, including speaker bureaus and advisory boards
Education, Registration & Certification:
- Bachelor's degree required
- MBA or other advanced degree is a plus
Experience:
- 3+ years of biotech/pharma marketing experience
- Experience in US launches and rare diseases is preferred
- Experience in sales or customer-facing roles is a plus
Skills, Knowledge & Abilities:
- Passion for understanding and championing the needs of people treating rare diseases, translating them into market-moving insights
- Proficiency or comfort with high science data and demonstrated ability to convert into promotional messaging
- Experience translating global brand strategy into affiliate HCP marketing execution, with depth in both personal and multi-channel marketing
- Ability to navigate and be successful in a fast-paced, results-driven environment, managing through ambiguity
- Commitment to collaboration and engagement, with a history of success leading in a matrix environment and with agency partners
- An entrepreneurial spirit coupled with the drive to embrace innovation and develop creative but well-reasoned solutions to business challenges
- Motivation to be a part of envisioning and building the infrastructure, systems, and tactics to ensure launch success
- Demonstrated integrity on the job, including an understanding of relevant rules and regulations
- Strong communication skills with the ability to influence across functions and varying levels of the organization
- Willing to travel domestically up to 30% of the time and attend events outside of business hours (e.g., occasional weekends and evenings)
Benefits and Perks:
Apellis offers a comprehensive benefits package, including a 401(k) plan with company match, inclusive family building benefits, flexible time off, summer and winter shutdowns, paid family leave, disability and life insurance, and more! Visit https://apellis.com/careers/ to learn more.
Company Background:
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases.
For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn
EEO Statement:
Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumoconiosis or any other characteristic protected under applicable federal, state or local law.
For San Francisco postings: Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records.
Other Duties:
Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice.
What We Do
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases where patients have few or no treatment options available. Our programs across ophthalmology, nephrology, hematology, and neurology are further exploring what is possible by targeting C3. For more information, please visit http://apellis.com.